vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and NACCO INDUSTRIES INC (NC). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $66.8M, roughly 1.9× NACCO INDUSTRIES INC). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs -5.8%, a 9.1% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs -5.2%). Over the past eight quarters, NACCO INDUSTRIES INC's revenue compounded faster (11.9% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
NACCO Industries, Inc. is an American publicly traded holding company, headquartered in Cleveland, Ohio. Through a portfolio of mining and natural resources businesses, the company operates under three business segments: Coal Mining, North American Mining, and Minerals Management. The Coal Mining segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The North American Mining se...
NATR vs NC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $66.8M |
| Net Profit | $4.1M | $-3.8M |
| Gross Margin | 72.5% | 18.0% |
| Operating Margin | 4.3% | 11.3% |
| Net Margin | 3.3% | -5.8% |
| Revenue YoY | 4.7% | -5.2% |
| Net Profit YoY | 1379.4% | -150.8% |
| EPS (diluted) | $0.23 | $-0.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $66.8M | ||
| Q3 25 | $128.3M | $76.6M | ||
| Q2 25 | $114.8M | $68.2M | ||
| Q1 25 | $113.2M | $65.6M | ||
| Q4 24 | $118.2M | $70.4M | ||
| Q3 24 | $114.6M | $61.7M | ||
| Q2 24 | $110.6M | $52.3M | ||
| Q1 24 | $111.0M | $53.3M |
| Q4 25 | $4.1M | $-3.8M | ||
| Q3 25 | $5.3M | $13.3M | ||
| Q2 25 | $5.3M | $3.3M | ||
| Q1 25 | $4.7M | $4.9M | ||
| Q4 24 | $-321.0K | $7.6M | ||
| Q3 24 | $4.3M | $15.6M | ||
| Q2 24 | $1.3M | $6.0M | ||
| Q1 24 | $2.3M | $4.6M |
| Q4 25 | 72.5% | 18.0% | ||
| Q3 25 | 73.3% | 13.0% | ||
| Q2 25 | 71.7% | 10.0% | ||
| Q1 25 | 72.1% | 14.7% | ||
| Q4 24 | 72.0% | 12.0% | ||
| Q3 24 | 71.3% | 11.7% | ||
| Q2 24 | 71.4% | 13.4% | ||
| Q1 24 | 71.2% | 13.2% |
| Q4 25 | 4.3% | 11.3% | ||
| Q3 25 | 7.0% | 8.8% | ||
| Q2 25 | 3.7% | -0.1% | ||
| Q1 25 | 5.4% | 11.7% | ||
| Q4 24 | 3.8% | 5.5% | ||
| Q3 24 | 4.6% | 31.9% | ||
| Q2 24 | 5.1% | 14.1% | ||
| Q1 24 | 4.2% | 8.9% |
| Q4 25 | 3.3% | -5.8% | ||
| Q3 25 | 4.2% | 17.3% | ||
| Q2 25 | 4.6% | 4.8% | ||
| Q1 25 | 4.2% | 7.5% | ||
| Q4 24 | -0.3% | 10.7% | ||
| Q3 24 | 3.8% | 25.4% | ||
| Q2 24 | 1.2% | 11.4% | ||
| Q1 24 | 2.1% | 8.6% |
| Q4 25 | $0.23 | $-0.53 | ||
| Q3 25 | $0.30 | $1.78 | ||
| Q2 25 | $0.28 | $0.44 | ||
| Q1 25 | $0.25 | $0.66 | ||
| Q4 24 | $-0.02 | $0.99 | ||
| Q3 24 | $0.23 | $2.14 | ||
| Q2 24 | $0.07 | $0.81 | ||
| Q1 24 | $0.12 | $0.61 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $49.7M |
| Total DebtLower is stronger | — | $100.8M |
| Stockholders' EquityBook value | $161.6M | $429.2M |
| Total Assets | $261.1M | $661.2M |
| Debt / EquityLower = less leverage | — | 0.23× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $49.7M | ||
| Q3 25 | $95.6M | $52.7M | ||
| Q2 25 | $81.3M | $49.4M | ||
| Q1 25 | $86.5M | $61.9M | ||
| Q4 24 | $84.7M | $72.8M | ||
| Q3 24 | $78.7M | $63.1M | ||
| Q2 24 | $68.7M | $62.4M | ||
| Q1 24 | $77.8M | $61.8M |
| Q4 25 | — | $100.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $99.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $29.0M | ||
| Q1 24 | $2.1M | $28.4M |
| Q4 25 | $161.6M | $429.2M | ||
| Q3 25 | $166.7M | $426.4M | ||
| Q2 25 | $163.7M | $413.1M | ||
| Q1 25 | $167.1M | $409.1M | ||
| Q4 24 | $161.0M | $404.9M | ||
| Q3 24 | $162.6M | $397.3M | ||
| Q2 24 | $156.4M | $384.1M | ||
| Q1 24 | $159.7M | $381.6M |
| Q4 25 | $261.1M | $661.2M | ||
| Q3 25 | $264.8M | $637.6M | ||
| Q2 25 | $254.9M | $631.3M | ||
| Q1 25 | $252.7M | $634.2M | ||
| Q4 24 | $240.9M | $631.7M | ||
| Q3 24 | $245.3M | $597.4M | ||
| Q2 24 | $235.8M | $560.1M | ||
| Q1 24 | $247.3M | $538.0M |
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | 0.01× | 0.07× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $11.4M |
| Free Cash FlowOCF − Capex | $7.6M | — |
| FCF MarginFCF / Revenue | 6.1% | — |
| Capex IntensityCapex / Revenue | 1.9% | — |
| Cash ConversionOCF / Net Profit | 2.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $11.4M | ||
| Q3 25 | $18.5M | $42.3M | ||
| Q2 25 | $4.3M | $-7.8M | ||
| Q1 25 | $2.6M | $5.0M | ||
| Q4 24 | $12.2M | $25.2M | ||
| Q3 24 | $9.6M | $2.8M | ||
| Q2 24 | $1.3M | $4.1M | ||
| Q1 24 | $2.2M | $-9.8M |
| Q4 25 | $7.6M | — | ||
| Q3 25 | $16.8M | — | ||
| Q2 25 | $3.0M | — | ||
| Q1 25 | $1.5M | — | ||
| Q4 24 | $10.0M | — | ||
| Q3 24 | $7.9M | — | ||
| Q2 24 | $-2.0M | — | ||
| Q1 24 | $-1.5M | — |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 13.1% | — | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 8.5% | — | ||
| Q3 24 | 6.9% | — | ||
| Q2 24 | -1.9% | — | ||
| Q1 24 | -1.4% | — |
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 3.3% | — |
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | 3.19× | ||
| Q2 25 | 0.81× | -2.39× | ||
| Q1 25 | 0.55× | 1.03× | ||
| Q4 24 | — | 3.33× | ||
| Q3 24 | 2.21× | 0.18× | ||
| Q2 24 | 0.97× | 0.68× | ||
| Q1 24 | 0.94× | -2.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
NC
| Transferred Over Time | $42.7M | 64% |
| Transferred At Point In Time | $24.1M | 36% |
